Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genenta Science
University of Washington
Yale University
University of California, San Francisco
ImmuneSensor Therapeutics Inc.
NuCana plc
Turnstone Biologics, Corp.
Sotio Biotech Inc.
Inhibrx Biosciences, Inc
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
Ikena Oncology
University of Florida
4D pharma plc
Incyte Corporation
Merck Sharp & Dohme LLC
Seagen Inc.